Pediatrics
Showing 1-5 of 5 Results
-
Molly Tanenbaum
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Clinical Associate Professor (By courtesy), Pediatrics - EndocrinologyBioDr. Tanenbaum is a clinical psychologist and clinical researcher committed to improving health and quality of life outcomes for people with diabetes. Dr. Tanenbaum’s research focuses on two main areas: 1) understanding and optimizing the role of technology (e.g. mobile technology/mHealth, diabetes devices, automated insulin delivery), and the feedback technology provides, to improve diabetes management; and 2) understanding the emotional experience of living with diabetes. Her recent work focused on developing a telehealth-based behavioral intervention for adults with type 1 diabetes to support adoption and sustained use of continuous glucose monitoring technology. She has expertise in using qualitative and mixed methods to take a human centered approach to understanding the context of living with and managing a chronic condition. Dr. Tanenbaum also has an interest in compassion-based approaches to addressing diabetes distress. As a licensed clinical psychologist, Dr. Tanenbaum provides consultation and behavioral medicine interventions with people living with diabetes.
-
Swaraj Thaman
Life Science Research Professional, Pediatrics - Endocrinology
Current Role at StanfordLife Science Research Professional 1, Translational Genomics of Diabetes Laboratory, Department of Pediatrics - Endocrinology, School of Medicine
-
Ngan (Phoebe) Tran
Postdoctoral Scholar, Endocrinology and Metabolism
BioNgan (Phoebe) Tran, Ph.D. is a Postdoctoral Research Scholar in the Translational Genomics of Diabetes Lab led by Dr. Anna Gloyn. She received her PhD in Clinical and Translational Science from Mayo Clinic, where she studied how mitochondrial genetics and dysfunction contribute to neurodegenerative diseases. Her doctoral research combined short- and novel long-read sequencing, clinical phenotyping, and functional approaches to investigate early-onset Parkinson’s disease, Lewy body dementia, mitochondrial quality control, and mitochondrial variation across healthy brain aging.
She is broadly interested in how genetic variation shapes mitochondrial function and how these effects translate into cellular and disease phenotypes. In the Gloyn Lab, she is extending this interest into metabolic disease by integrating human genetics with functional and metabolic studies. Her long-term research interests lie at the intersection of mitochondrial biology, functional genomics, and translational medicine, with the goal of connecting human genetic discoveries to mechanisms that may ultimately inform therapeutic strategies.
